Inovio Pharmaceuticals In...

NASDAQ: INO · Real-Time Price · USD
1.85
0.23 (14.20%)
At close: Aug 15, 2025, 3:00 PM

Inovio Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-107.25M -135.12M -279.82M -303.66M
Depreciation & Amortization
3.13M 3.5M 5.5M 4.73M
Stock-Based Compensation
6.6M 11.07M 22.56M 26.34M
Other Working Capital
-504.04K 26.4M -9.07M 13.18M
Other Non-Cash Items
-3.88M 6.47M 11.69M 858.64K
Deferred Income Tax
n/a -32.05K 4.03M 5.67M
Change in Working Capital
-2.66M -10.26M 19.83M 50.35M
Operating Cash Flow
-104.08M -124.37M -216.22M -215.71M
Capital Expenditures
-487.83K -320.9K -969.15K -1.23M
Cash Acquisitions
n/a 6.22M -2M 1,435.8B
Purchase of Investments
-54.14M -203.48M -248.53M -348.95M
Sales Maturities Of Investments
158.64M 284.93M 361.08M 174.84M
Other Investing Acitivies
-428.51K n/a n/a -1,435.8B
Investing Cash Flow
104.07M 87.36M 109.59M -175.34M
Debt Repayment
-16.41M n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
31.86M -466.65K -1.11M 2.06M
Financial Cash Flow
51.48M 5M 81.84M 211.5M
Net Cash Flow
51.5M -32.02M -24.81M -179.58M
Free Cash Flow
-104.56M -124.69M -217.18M -216.94M